Secukinumab
Products Secukinumab was approved as an injectable in many countries in 2015 (Cosentyx / -SensoReady). Structure and properties Secukinumab is a human IgG1κ monoclonal antibody. It is produced by biotechnological methods. The molecular mass is approximately 151 kDa. Effects Secukinumab (ATC L04AC10) binds to the cytokine interleukin-17A (IL-17A) and inhibits interaction with its receptor. As … Secukinumab
